MAKINDO MEDICINE · Biochemistry289
Biochemistry III: enzymes, vitamins, genetics and molecular mechanisms
Core principles: mechanisms are emphasised to explain clinical phenomena, physiological measurements and biochemical disease.
Enzyme kinetics and inhibition
| Concept | Definition | Practical meaning |
|---|---|---|
| Michaelis–Menten Km | Substrate concentration at half Vmax in simple model | Lower Km often means higher apparent affinity but context matters |
| Competitive inhibitor | Raises apparent Km, Vmax unchanged | Surmountable by high substrate concentration |
| Non-competitive pure inhibition | Lowers Vmax, Km unchanged | Cannot fully overcome by substrate |
| Uncompetitive inhibition | Lowers Km and Vmax | Binds enzyme-substrate complex |
| Allostery/cooperativity | Sigmoidal kinetics not simple MM | Haemoglobin, regulatory enzymes |
Water- and fat-soluble vitamins with clinical relevance
| Vitamin | Biochemical role | Deficiency example |
|---|---|---|
| B1 thiamine | Pyruvate dehydrogenase, alpha-KGDH, transketolase | Wernicke encephalopathy, beriberi |
| B2 riboflavin | FMN/FAD redox cofactors | Cheilosis, glossitis |
| B3 niacin | NAD/NADP redox | Pellagra (dermatitis, diarrhoea, dementia) |
| B5 pantothenate | Coenzyme A synthesis | Rare; multisystem symptoms |
| B6 pyridoxine | Transamination, neurotransmitter/haem synthesis | Neuropathy, seizures, sideroblastic anaemia |
| B7 biotin | Carboxylases | Dermatitis, alopecia, metabolic acidosis |
| B9 folate | One-carbon transfer, thymidylate and purine synthesis | Megaloblastic anaemia; fetal neural tube risk |
| B12 cobalamin | Methionine synthase and methylmalonyl-CoA mutase | Megaloblastosis and neuropathy |
| C ascorbate | Collagen prolyl/lysyl hydroxylation, antioxidant | Scurvy |
| A retinoids | Visual cycle and epithelial differentiation | Night blindness |
| D calcitriol | Calcium/phosphate absorption and bone mineral balance | Osteomalacia/rickets |
| E tocopherol | Lipid membrane antioxidant | Haemolysis, neurological dysfunction |
| K phylloquinone | Gamma-carboxylation coagulation proteins | Bleeding, prolonged PT |
Genetics, RNA and protein synthesis
- DNA replication uses DNA polymerases with proofreading (except several organelle/specialised contexts); telomerase extends terminal repeats in selected cells.
- Transcription by RNA polymerase II forms pre-mRNA, which undergoes capping, splicing and polyadenylation; alternative splicing increases protein diversity.
- Ribosomes translate mRNA codons with aminoacyl-tRNAs; initiation, elongation and termination require specialised factors.
- Autosomal dominant, recessive, X-linked and mitochondrial inheritance patterns each have characteristic pedigrees but penetrance, expressivity and de novo variation modify them.
- Epigenetic DNA methylation/histone modification can alter transcription without DNA sequence change; genomic imprinting depends on parent of origin.
Cell signalling and tissue consequences
- G-protein coupled receptors: Gs increases cAMP/PKA; Gi decreases cAMP; Gq activates PLC → IP3/DAG → cytosolic Ca2+ and PKC.
- Insulin receptor tyrosine kinase recruits IRS/PI3K/AKT to promote GLUT4 translocation, glycogenesis and anabolic signalling.
- p53 responds to DNA damage by cell-cycle arrest, senescence or apoptosis; Rb restrains E2F until appropriately phosphorylated.
- Mitochondrial apoptosis is regulated by BCL2 family and cytochrome c/caspase activation; necroptosis and pyroptosis are distinct regulated death pathways.
Molecular diagnostics and clinical genetics
- Enzyme kinetics: Competitive inhibition raises apparent Km without changing Vmax; non-competitive inhibition may lower Vmax. Enzyme assay interpretation requires attention to cofactors, substrate concentration and tissue source.
- Variant interpretation: A variant of uncertain significance is not a molecular diagnosis. Classification integrates segregation, population frequency, functional data and phenotype; reclassification may occur as evidence changes.
- DNA to protein: Replication proceeds 5′→3′ using polymerases and proofreading; transcription makes RNA and splice processing determines mature transcripts; translation converts codons to protein. Missense, nonsense, frameshift and splice variants can have different consequences.
- Genomic testing: Sequence tests detect many single-nucleotide variants but may miss copy-number changes, repeat expansions and structural rearrangements unless specific methods are included. Mitochondrial heteroplasmy and tissue mosaicism add further sensitivity limits.
Vitamin cofactor clinical patterns
- B1 and B6: Thiamine supports pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase; deficiency contributes to Wernicke encephalopathy, beriberi and lactic acidosis. Pyridoxal phosphate supports amino-acid metabolism and neurotransmitter synthesis; deficiency can cause neuropathy or seizures.
- B9 and B12: Folate and cobalamin are essential for nucleotide synthesis; both can cause macrocytosis, but B12 deficiency also causes subacute combined degeneration and peripheral neuropathy. Serum markers and test limitations matter before treatment.
- Fat-soluble vitamins: Vitamin A affects vision and epithelial differentiation, D calcium-phosphate homeostasis, E antioxidant protection and K gamma-carboxylation of coagulation proteins. Malabsorption, liver disease and medication exposures can alter status.
Further reading: OpenStax Anatomy & Physiology; USMLE Step 1 framework. Apply current specialist guidance for patient-care decisions. Educational expansion pending clinical editorial sign-off (2026).
End of chapter